1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60AAC923DA4446719002586F60042831D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-optimal-resource-planning-for-successful-product-launch?OpenDocument&Email=
18
19OpenDocument&Email=
2044.210.149.205
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services Product Launch Resource Allocation

White Paper: Optimal Resource Planning for a Successful Product Launch

Whitepaper Image

ID: BEB-88


Pages/Slides: 7


Published: 2021


Delivery Format: PDF


 

License Options:


Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
The launch environment has never been as challenging for pharma as it is now.

While the pandemic has changed many aspects of the launch dynamic, some things remain the same: maximizing the uptake curve at product launch is driven by valuable positioning, aligned pre-launch stakeholder engagement, and preparedness.

A significant factor in reaching these goals is appropriate resourcing (spend and team) for the right mix of commercial and medical activities, with the right timing and sequence.

Best Practices, LLC conducted primary benchmarking research – spotlighted in this white paper – to identify investment benchmarks for launch activities during the four budget years leading up to launch. The research findings will support brand and marketing leaders in developing optimal total resourcing plans and fund allocations for their new brands based on Peak-Year Sales Forecast, Market Archetype, Product Type, and Physician Type.

Specifically, the findings and benchmarks address:

  • Industry investments for new pharmaceutical product launch from 3 years prior to launch, through launch year
  • Budget allocation to key marketing, education and market access activities during and prior to launch
  • Investment timing for 50+ launch activities
  • FTE allocation to key launch activities
  • Budget and activity trends
  • Top launch success factors
Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies